Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000

P Ralaimazava; R Durand; N Godineau; A Keundjian; Z Jezic; B Pradines; O Bouchaud; J Le Bras

doi:10.2807/esm.07.07.00355-en

Scientific review Open Access

Like 0

This item has no PDF Download

Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000
P Ralaimazava¹ , R Durand¹ , N Godineau² , A Keundjian³ , Z Jezic¹ , B Pradines³ , O Bouchaud⁴ , J Le Bras¹
View Affiliations Hide Affiliations

Affiliations: ¹ National reference centre for malaria chemosusceptibility, Hôpital Bichat-Claude-Bernard, Paris ² Parasitology Unit, Hôpital Delafontaine, Saint-Denis ³ Institute for tropical medicine of the Army health services, Marseille ⁴ Infectious and tropical diseases Unit A, Hôpital Bichat-Claude-Bernard, Paris

Correspondence:
View Citation Hide Citation

Citation style for this article: Ralaimazava P, Durand R, Godineau N, Keundjian A, Jezic Z, Pradines B, Bouchaud O, Le Bras J. Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill. 2002;7(7):pii=355. https://doi.org/10.2807/esm.07.07.00355-en

Abstract

In 2000, the chemosusceptibility of imported malaria was stable in France. All countries of infection considered, the bi-resistance to chloroquine and cycloguanil has not changed from 1996 to 2000. The monotherapy using quinine or mefloquine remains the first-line treatment to falciparum malaria. Resistance to these two antimalarials is rare in Africa and has not evolved over the past 15 years.